News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Rock Springs Capital Management LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G
| Rock Springs Capital Management LP reports a 5.6% stake in AEGLEA BIOTHERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G
| Rock Springs Capital Management LP reports a 5.4% stake in AGIOS PHARMACEUTICALS, INC. |
| 04/25/2022 |
SC 13G
| Rock Springs Capital Management LP reports a 6.1% stake in Inozyme Pharma, Inc. |
| 02/15/2022 |
SC 13G
| Rock Springs Capital Management LP reports a 5.1% stake in MEREO BIOPHARMA GROUP PLC |
| 01/03/2022 |
SC 13G
| Rock Springs Capital Management LP reports a 11.5% stake in Tempest Therapeutics, Inc. |
| 12/30/2021 |
SC 13G
| Rock Springs Capital Management LP reports a 5.4% stake in Compass Therapeutics, Inc. |
| 07/08/2021 |
SC 13G
| Rock Springs Capital Management LP reports a 9.7% stake in Tempest Therapeutics, Inc. |
| 06/24/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/17/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/19/2021 |
SC 13G
| Rock Springs Capital Management LP reports a 5.3% stake in Immunocore Holdings plc |
| 03/01/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/16/2020 |
SC 13G
| Rock Springs Capital Management LP reports a 5.6% stake in PhaseBio Pharmaceuticals, Inc. |
| 10/26/2020 |
SC 13G
| Rock Springs Capital Management LP reports a 5.2% stake in Aclaris Therapeutics, Inc. |
| 10/19/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/19/2020 |
SC 13G
| Rock Springs Capital Management LP reports a 7.4% stake in Spruce Biosciences, Inc. |
| 10/02/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/16/2019 |
SC 13G
| Rock Springs Capital Management LP reports a 6.1% stake in Mirum Pharmaceuticals, Inc. |
| 10/11/2019 |
SC 13G
| Rock Springs Capital Management LP reports a 4.5% stake in Aprea Therapeutics, Inc. |
| 10/07/2019 |
SC 13G
| Rock Springs Capital Management LP reports a 5.1% stake in Assembly Biosciences, Inc. |
| 09/27/2019 |
SC 13G
| Rock Springs Capital Management LP reports a 5.1% stake in Ardelyx, Inc. |
| 07/29/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/22/2019 |
SC 13G
| Rock Springs Capital Management LP reports a 5.2% stake in PhaseBio Pharmaceuticals, Inc. |
| 11/02/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/07/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/10/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 05/16/2016 |
SC 13G
| Rock Springs Capital Management LP reports a 5.1% stake in Collegium Pharmaceutical, Inc. |
|
|